SCHEMBL4435587

SCHEMBL4435587

Cn1c(Nc2ccccc2)ncc(-c2ccc(O)cn2)c1=O.Cn1c(Nc2ccccc2)ncc(-c2ccc(Oc3ccnc(N)c3)cn2)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 5/20 0.41
LCK P06239 2/20 0.41
KDR P35968 2/20 0.41
MST1R Q04912 2/20 0.41
AURKA O14965 1/20 0.41
RPS6KA5 O75582 1/20 0.41
PIM1 P11309 1/20 0.41
HGF P14210 1/20 0.41
RPS6KB1 P23443 1/20 0.41
MAPK9 P45984 1/20 0.41
TEK Q02763 1/20 0.41
BTK Q06187 1/20 0.41
RAF1 P04049 2/20 0.41
BRAF P15056 2/20 0.41
P2RX3 P56373 4/20 0.38
CSF1R P07333 4/20 0.36
PDGFRA P16234 3/20 0.36
FLT3 P36888 2/20 0.36
PDGFRB P09619 2/20 0.36
KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3564189 0.95 MET (0.44) METLCKKDRMST1RAURKA
SCHEMBL13462897 0.84 CSF1R (0.39) METLCKKDRMST1RAURKA
SCHEMBL3564629 0.84 WEE1 (0.43) METPDGFRAPDGFRBCYP2C9WEE1
SCHEMBL3559873 0.83 MET (0.48) METLCKKDRMST1RAURKA
SCHEMBL16083963 0.79 MET (0.43) METLCKKDRMST1RAURKA
SCHEMBL3558835 0.78 MET (0.43) METLCKKDRMST1RAURKA
SCHEMBL3562448 0.78 BRAF (0.43) METLCKKDRMST1RAURKA
SCHEMBL16076007 0.78 MET (0.44) METLCKKDRMST1RAURKA
SCHEMBL16083969 0.77 MET (0.49) METLCKKDRMST1RAURKA
SCHEMBL16076011 0.77 KDR (0.43) METLCKKDRMST1RAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125781-A2 SUBSTITUTED HETEROCYCLES AND METHODS OF USE Amgen Inc. (US) 2009-12-02 EP disclosed
WO-2008079291-A2 SUBSTITUTED HETEROCYCLES AND METHODS OF USE AMGEN INC. (US) 2008-07-03 WO disclosed